Company / SG&A per Share
CLOVER HEALTH INVESTMENTS, CORP. /DE SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.44
FY2025
5-year range
$0.36 / $2.30
FY2021-FY2025
Trend
+23.4%
vs FY2024
Sector context
#151 of 156
Health Care
What the data says
Among 156 Health Care companies, CLOVER HEALTH INVESTMENTS, CORP. /DE is in the top 3% for sg&a per share. SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $0.44.
Based on SEC 10-K filings.
0.44 in FY2025 with a 5-year CAGR of -20.1%.
Increased from $0.38 to $0.44 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -42.2%
- 5-Year CAGR
- -20.1%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 156This company $0.44 Sector average $11421.56
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 23.4% year-over-year.
- Ranks #151 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.44 | +23.4% |
| FY2024 | $0.36 | -5.2% |
| FY2023 | $0.38 | -83.5% |
| FY2022 | $2.30 | +8.9% |
| FY2021 | $2.11 | +54.9% |
| FY2020 | $1.36 | +25.0% |
| FY2019 | $1.09 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026